Impact Factor
1.70
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
0.30
47 total citations
h5-index
7
h5 depth signal
Cited share
21.0%
33 of 157
Total citations
47
Citation footprint
Metric signal
0.29
External metric anchor
Self-citation
14.9%
7 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
India
944
United States
36
Saudi Arabia
24
Mexico
21
Nigeria
20
Citing Fields of Research
Dermatology
786
Allergies
265
Fungal Pathogenesis
117
Auto-Inflammatory Disorders
113
Musculoskeletal Disorders
82
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,256
Articles tracked across the journal lifetime
Indexed publication set
157
33 cited publications
Last 12 months
114
10.4 publications/month
Open access share
85.1%
97 OA publications in the last year
Leading citing country
India
944 citing publications
Leading citing field
Dermatology
786 citing publications
Latest tracked publication
8 October 2026
10 recent records available
Coverage & Indexing History
Cataloged NLM Record
This journal is currently cataloged and verified in the National Library of Medicine (NLM) database. Coverage details include: 2015-.
Research Focus & Classification
Indexed Subjects
Dermatology
Broad Categories
Dermatology
Allergies
Epithelial Barriers
Musculoskeletal Disorders
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.18203/issn.2455-4529.intjresdermatol20263696
Open DOI
Efficacy and tolerability of a multi-ingredient nutraceutical on facial skin ageing parameters and self-reported wellbeing: a prospective, open-label and single-arm pilot study
Background: Skin ageing involves interconnected changes in extracellular matrix integrity, hydration, oxidative stress and cellular resilience. This study evaluated the efficacy and tolerability of RESET by IQ HEALTH™, a multi-ingredient...
02
DOI 10.18203/issn.2455-4529.intjresdermatol20263691
Open DOI
Incidence of HIV among Herpes Zoster patients in Khartoum dermatology and venereal disease teaching hospital from April 2018 to April 2019
Background: Herpes zoster (HZ) results from reactivation of latent varicella-zoster virus and is associated with ageing and impaired cell-mediated immunity, including HIV infection. Aim was to estimate the proportion of HIV-positive pati...
03
DOI 10.18203/issn.2455-4529.intjresdermatol20263683
Open DOI
Clinico-epidemiological profile of pityriasis versicolor among Sudanese patients attending Khartoum dermatology and STI teaching hospital
Background: Pityriasis versicolor (PV) is a mild, chronic, superficial fungal infection of the stratum corneum caused by Malassezia species. The condition is common in tropical climates and frequently affects adolescents and young adults...
04
DOI 10.18203/issn.2455-4529.intjresdermatol20263680
Open DOI
Efficacy and safety of MemBioTM intense moisturizer: barrier repair beyond hydration
Background: Dry skin is characterized by epidermal barrier dysfunction and depletion of stratum corneum lipids, leading to decreased hydration and increased transepidermal water loss (TEWL). MemBioTM Intense Moisturizer (test product) wa...
05
DOI 10.18203/issn.2455-4529.intjresdermatol20263681
Open DOI
Evidence and a proposed algorithm for periprocedural treatment sequencing in melasma
Melasma treatment often combines photoprotection, topical depigmenting agents, oral tranexamic acid and procedures. Evidence for individual treatments is more developed than evidence for their order, spacing and periprocedural care. This...
06
DOI 10.18203/issn.2455-4529.intjresdermatol20263277
Open DOI
Clinical spectrum of cutaneous adverse drug reactions in the peri procedural period: a case series
Cutaneous adverse drug reactions (CADRs) are among the frequent adverse effects of medications prescribed during the postoperative period. Their diverse clinical presentations often pose diagnostic challenges, particularly when eruptions...
07
DOI 10.18203/issn.2455-4529.intjresdermatol20263252
Open DOI
Beyond millijoules: a six-dimensional tissue-dose model for fractional ablative carbon dioxide laser therapy
Fractional ablative carbon dioxide (CO2) laser treatment is commonly documented with displayed parameters such as pulse energy, power, pulse duration, density level and number of passes. These settings are device-specific inputs, not a p...
08
DOI 10.18203/issn.2455-4529.intjresdermatol20262849
Open DOI
Herpetic folliculitis: a lesser-known folliculitis and a review of herpes infections
Herpetic folliculitis is a rare disease that involves the pilosebaceous units. It is caused by varicella zoster virus or by herpes simplex virus. It is an infrequently reported entity in literature. Presentations of this disease are quit...
09
DOI 10.18203/issn.2455-4529.intjresdermatol20262843
Open DOI
Clinical and safety outcomes of a prospective, eight-week and monocentric study of a multi-active topical serum in facial hyperpigmentation in Indian skin
Background: Facial hyperpigmentation is a common dermatological concern in individuals with Fitzpatrick skin phototypes III-IV. Current treatment options are often limited by tolerability issues and restrictions on long-term hydroquinone...
10
DOI 10.18203/issn.2455-4529.intjresdermatol20262851
Open DOI
Systemic medication as a safety variable in dermatologic laser and energy-based device procedures: a practical risk-stratification framework
Dermatologic laser and energy-based device procedures are increasingly performed in patients receiving systemic medication. Traditional pre-procedure screening often treats selected drugs as binary contraindications, although the relevan...
Bibliographical & Catalog Notes
Also issued online.